"Designing Growth Strategies is in our DNA"

Medical Device Recall Management Services Market Size, Share & Industry Analysis, By Service Type (Recall Strategy & Compliance, Recall Execution & Management, Retrieval & Reverse Logistics, Field Correction & Closure), By Recall Action (Product Removal & Return, On-site Correction, Repair & Modification), By Medical Device Type (Implantable Devices, Capital & Durable Equipment, Disposable Devices, IVD Devices, and Others), By Client Type (Medical Device Manufacturers, Contract Manufacturers/OEMs, Importers & Distributors, Hospitals & Health Systems), and Regional Forecast, 2026-2034

Last Updated: October 01, 2026 | Format: PDF | Report ID: FBI119299

 

Medical Device Recall Management Services Market Size and Future Outlook

Play Audio Listen to Audio Version

The global medical device recall management services market size was valued at USD 1.68 billion in 2025. The market is projected to grow from USD 1.81 billion in 2026 to USD 3.30 billion by 2034, exhibiting a CAGR of 7.8% during the forecast period.

Medical device recall management services help companies and healthcare providers handle defective or non-compliant product withdrawals. These third-party or software solutions coordinate regulatory reporting (such as FDA 806 filings), customer notices, reverse logistics, device inspection or rework, and final closure documentation. Market growth is mainly driven by the increasing product recalls globally, which is influencing key players to expand their service offerings.

IQVIA Inc., Sedgwick, Inmar Inc., and Wipro Limited held the highest market share in 2025 due to their strong global footprint and broad range of service offerings, along with significant focus on increasing investments.

AI-Enabled Post-Market and Recall Workflow Automation to Emerge as a Key Trend

Currently, recall management companies are increasingly using artificial intelligence (AI) and automated platforms instead of manual spreadsheets and call-center processes. These solutions can automate complaint intake, case prioritization, notifications, reporting, and reconciliation. AI also helps identify affected customers and summarize information, while human review remains important for regulatory decisions. This improves efficiency, scalability, and integration with systems such as QMS, ERP, and device databases.

  • For instance, in April 2026, Wipro announced that a leading global MedTech company selected its AI-enabled solution to improve post-market surveillance and automate health-authority reporting and case prioritization.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Medical-Device Recalls and Regulatory Scrutiny to Accelerate Market Growth

In recent years, the surge in the number of medical-device recalls and stricter regulatory requirements are driving demand for recall management services. Manufacturers need support for regulatory reporting, customer notification, product retrieval, field correction, and recall closure. As a result, outsourcing becomes particularly important for large, complex, or high-risk recalls that require quick and coordinated action. This is anticipated to drive the global medical device recall management services market growth in the coming years.

  • For instance, in February, Sedgwick reported 3,232 U.S. recalls across five industries in 2024, with medical-device recalls reaching a four-year high.

Market Drivers - Impact & CAGR Contribution (2026–2034)

Rank Market Driver Overall Impact Rank CAGR Contribution, 2026–2034 Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Rising medical-device recall activity and regulatory scrutiny. High 2.80% High High High
2 Growth in connected/software-enabled devices and cybersecurity-related corrections. Medium-High 2.35% Medium High High
3 Increasing outsourcing of end-to-end recall execution and field actions. Medium-High 1.95% Medium Medium High
4 Cross-border device distribution, UDI/traceability and multi-country compliance requirements. Medium-High 1.70% Medium Medium High
5 Expansion of field correction, reverse logistics and digital case-management services. Medium 1.35% Medium Medium Medium
6 Others (emerging-market regulation, provider expansion, service-price inflation, hospital automation). Low 0.71% Low Low Low
Total Positive Growth Contribution 10.86%  

Source: Fortune Business Insights

Download Free sample For In-Depth Market Restraints & Risk Analysis

MARKET RESTRAINTS

Outsourcing Limitations Due to In-House Recall Management Hinder Market Expansion

Many large manufacturers continue to manage recall strategy, regulatory reporting, and medical device quality management activities internally. Additionally, third-party providers are generally used only for large, complex, or geographically widespread recalls. Moreover, recall volumes can vary significantly from year to year, creating inconsistent demand for external services. This is anticipated to hinder market growth during the forecast period.

  • For instance, Sedgwick reported that U.S. medical-device recall events declined by 8.0% in 2025, despite an increase in the number of affected units.

Market Restraints - Impact & Negative CAGR Contribution (2026–2034)

Rank Market Restraints Overall Impact Rank Negative CAGR Contribution (2026-2034) Impact: 2026-2028 Impact: 2029-2031 Impact: 2032-2034
1 Episodic recall volumes and continued in-house execution limit outsourcing penetration. High -1.25% High High High
2 High cost and integration complexity of multi-jurisdiction recall programs. Medium-High -0.85% High Medium Medium
3 Data fragmentation, traceability gaps, and interoperability limitations. Medium -0.65% Medium Medium Medium
4 Others (procurement pressure, liability concerns, workforce constraints, platform security requirements). Low -0.31% Low Low Low
Total Negative Growth Impact -3.06%  

Source: Fortune Business Insights

Download Free sample For In-Depth Market Restraints & Risk Analysis

MARKET OPPORTUNITIES

Software, Firmware and Cybersecurity Remediation to Create Growth Opportunities

In recent years, the growing use of connected and software-enabled medical devices is creating opportunities for digital recall services. Many issues can now be corrected remotely through software patches, firmware updates, and cybersecurity fixes. Moreover, the service providers can support device identification, customer communication, patch deployment, technical assistance, and confirmation that corrective actions were completed.

  • For instance, in February 2026, the FDA updated its medical-device cybersecurity guidance, strengthening cybersecurity risk-management requirements throughout the device lifecycle.

MARKET CHALLENGES

Cross-Border Coordination, Traceability and Data Fragmentation to Challenge Market Growth

Global medical device recalls are difficult to manage, as regulatory requirements, reporting timelines, languages, and distribution systems vary across countries. In addition, data may be spread across ERP, QMS, complaint, UDI, and hospital systems, making it difficult to identify affected devices and confirm recall completion. This can increase recall time and costs, which is expected to pose a major challenge for market expansion.

  • For instance, the mandatory use of several EUDAMED modules from May 2026 increases device traceability and requires manufacturers to adapt their systems and processes to new EU data requirements.

Segmentation Analysis

By Service Type

Need to Reconcile Recalled Medical Devices Boosted Retrieval & Reverse Logistics Segment Growth

Based on service type, the market is segmented into recall strategy & compliance, notification & communication, recall execution & management, retrieval & reverse logistics, field correction & closure, and others.

The retrieval & reverse logistics segment accounted for the largest global medical device recall management services market share in 2025. The segment growth is driven by the need to locate, collect, transport, quarantine, and reconcile recalled medical devices across hospitals, distributors, and other healthcare facilities.

The recall execution & management segment is projected to grow at a CAGR of 8.3% during the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Recall Action

Safety Risk of Recalled Devices Fueled Product Removal & Return Segment Growth

By recall action, the market is segmented into product removal & return, on-site correction, repair & modification, software/firmware correction, relabeling & replacement, and others.

The product removal & return segment accounted for the largest market share in 2025. Physical removal is required when a recalled device may pose a safety risk, cannot be fixed adequately through software or field correction, or needs to be replaced. This is expected to drive the segment’s growth during the forecast period. Moreover, the segment is expected to hold a 34.3% share in 2026.

The repair & modification segment is anticipated to grow at a CAGR of 8.7% over the forecast period.

By Medical Device Type

Widespread Installed Base of Capital & Durable Equipment Boosted Segment Growth

By medical device type, the market is classified into implantable devices, capital & durable equipment, disposable devices, IVD devices, connected & software-enabled devices, and others.

The capital & durable equipment segment accounted for the largest market share in 2025. These devices remain in use for many years and are widely installed across hospitals and diagnostic facilities. When recalls occur, they often require on-site inspection, repair, part replacement, software updates, and documentation, creating strong demand for recall management services. Moreover, the segment is expected to hold a 24.3% share in 2026.

The implantable devices segment is expected to grow at a CAGR of 8.0% during the forecast period.

By Client Type

Primary Responsibility for Recall Decisions and Regulatory Reporting Fueled Medical Device Manufacturers Segment Growth

On the basis of client type, the market is segmented into medical device manufacturers, contract manufacturers/OEMs, importers & distributors, hospitals & health systems, and others.

In 2025, medical device manufacturers dominated the market, as they are primarily responsible for recall decisions, regulatory reporting, customer communication, corrective actions, and product retrieval. As a result, they are the main users of outsourced recall management services. Furthermore, the segment is set to hold a 58.6% market share in 2026.

  • For instance, as of August 2026, Wipro’s post-market surveillance services support medical-device manufacturers across more than 120 countries and 60+ languages, highlighting the large scale of outsourced manufacturer requirements.

The contract manufacturers/OEMs segment is projected to grow at a CAGR of 10.6% during the forecast period.

Medical Device Recall Management Services Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America Medical Device Recall Management Services Market Size, 2025 (USD Billion)

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest share in 2024, valued at USD 0.73 billion, and maintained its leading position in 2025, with USD 0.78 billion. The region’s dominance is supported by mature regulatory enforcement and high penetration of specialist recall providers in the U.S. and Canada.

U.S. Medical Device Recall Management Services Market

In 2026, the U.S. is anticipated to reach USD 0.77 billion, accounting for approximately 42.6% of global sales.

Europe

Europe is projected to record a CAGR of 6.5% during the forecast period, the second-highest globally. The market is expected to reach USD 0.50 billion in 2026. The region’s growth is supported by a large number of medical device manufacturers, which is leading to a large number of medical device recalls and increasing demand for related services.

U.K. Medical Device Recall Management Services Market

The U.K. market is projected to reach USD 0.08 billion in 2026, representing approximately 4.3% of global sales.

Germany Medical Device Recall Management Services Market

The market in Germany is expected to reach USD 0.12 billion in 2026, accounting for approximately 6.4% of global revenues.

Asia Pacific

In 2026, Asia Pacific is projected to reach approximately USD 0.35 billion, making it the third-largest market. Medical device manufacturing, distribution networks, and regulatory oversight continue to expand across China, Japan, Australia, and other countries, which is expected to drive the demand for recall management services.

  • For instance, according to the IBEF data, the Indian medical devices sector is projected to reach USD 50.1 billion by 2030 due to rising healthcare demand, increased investments, and strong policy support.

Japan Medical Device Recall Management Services Market

Japan is projected to reach approximately USD 0.08 billion in 2026, representing nearly 4.3% of global sales.

China Medical Device Recall Management Services Market

In 2026, China is anticipated to reach USD 0.11 billion, accounting for approximately 6.1% of global sales.

India Medical Device Recall Management Services Market

In 2026, India is anticipated to reach USD 0.04 billion, accounting for approximately 2.4% of global sales.

Latin America and Middle East & Africa

Latin America and the Middle East & Africa are anticipated to witness moderate growth during the forecast period. The Latin America market is estimated to reach approximately USD 0.07 billion in 2026. Market growth in Latin America is supported by increasing medical device imports and stronger post-market monitoring, which is raising the need for product tracking, customer notification, retrieval, and field-correction services. Moreover, the market growth of the Middle East & Africa is mainly attributed to improving medical-device regulation and healthcare infrastructure.

GCC Medical Device Recall Management Services Market

In 2026, the GCC market is estimated to reach approximately USD 0.02 billion, representing around 1.4% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Acquisition, Geographic Expansion, and Other Strategies will Assist in Boosting Market Share

In 2025, IQVIA Inc., Sedgwick, Inmar Inc., and Wipro Limited held the largest global market share. The companies compete on global reach, regulatory expertise, recall execution capabilities, reverse logistics, field remediation, multilingual communication, and digital recall-management platforms. Moreover, other prominent players are focusing on expanding their service offerings in underserved countries to strengthen their global footprint and gain a significant market share in the coming years.

LIST OF KEY MEDICAL DEVICE RECALL MANAGEMENT SERVICE COMPANIES PROFILED

KEY INDUSTRY DEVELOPMENTS

  • April 2026: UL LLC agreed to acquire Eurofins Scientific’s Electrical & Electronics business, including medical-device testing capabilities.
  • November 2025: DHL acquired SDS Holdings, expanding U.S. medical and healthcare logistics capabilities.
  • November 2025: United Parcel Service of America, Inc. completed its USD 1.6 billion acquisition of Andlauer Healthcare Group, expanding complex healthcare logistics capabilities.
  • April 2025: Inmar Inc. expanded its MMCAP Infuse agreement and deployed OneRecall across a network serving more than 34,500 member facilities.
  • February 2025: Freyr achieved ISO 13485:2016 certification from BSI for services supporting the medical-device industry.
  • February 2025: Freyr launched Market Intel, a regulatory market-intelligence service supporting medical-device organizations.
  • October 2024: RQM+ and 3Aware formed a partnership combining aiSurveillance real-world evidence technology with MedTech regulatory expertise.

REPORT COVERAGE

The report provides a comprehensive analysis of the global medical device recall management services market across its key segments, highlighting the major drivers, restraints, opportunities, trends, and challenges influencing market growth. It also covers key industry developments, major medical device recalls, the competitive landscape, market share analysis, and detailed profiles of leading companies operating in the market.

Request for Customization   to gain extensive market insights.


Report Scope and Segmentation

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year  2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 7.8% from 2026 to 2034
Unit Value (USD Billion)
Segmentation By Service Type, Recall Action, Medical Device Type, Client Type, and Region
By Service Type
  • Recall Strategy & Compliance
  • Notification & Communication
  • Recall Execution & Management
  • Retrieval & Reverse Logistics
  • Field Correction & Closure
  • Others
By Recall Action
  • Product Removal & Return
  • On-site Correction
  • Repair & Modification
  • Software/Firmware Correction
  • Relabeling & Replacement
  • Others
By Medical Device Type
  • Implantable Devices
  • Capital & Durable Equipment
  • Disposable Devices
  • IVD Devices
  • Connected & Software-Enabled Devices
  • Others
By Client Type
  • Medical Device Manufacturers
  • Contract Manufacturers/OEMs
  • Importers & Distributors
  • Hospitals & Health Systems
  • Others
By Region 
  • North America (By Service Type, Recall Action, Medical Device Type, Client Type, and Country)
    • U.S. (Medical Device Type)
    • Canada (Medical Device Type)
  • Europe (By Service Type, Recall Action, Medical Device Type, Client Type, and Country/Sub-region)
    • Germany (Medical Device Type)
    • U.K. (Medical Device Type)
    • France (Medical Device Type)
    • Spain (Medical Device Type)
    • Italy (Medical Device Type)
    • Scandinavia (Medical Device Type)
    • Rest of Europe (Medical Device Type)
  • Asia Pacific (By Service Type, Recall Action, Medical Device Type, Client Type, and Country/Sub-region)
    • China (Medical Device Type)
    • Japan (Medical Device Type)
    • India (Medical Device Type)
    • Australia (Medical Device Type)
    • Southeast Asia (Medical Device Type)
    • Rest of Asia Pacific (Medical Device Type)
  • Latin America (By Service Type, Recall Action, Medical Device Type, Client Type, and Country/Sub-region)
    • Brazil (Medical Device Type)
    • Mexico (Medical Device Type)
    • Rest of Latin America (Medical Device Type)
  • Middle East & Africa (By Service Type, Recall Action, Medical Device Type, Client Type, and Country/Sub-region)
    • GCC (Medical Device Type)
    • South Africa (Medical Device Type)
    • Rest of Middle East & Africa (Medical Device Type)

Research Methodology

1. Bottom Up Approaches

Approach 1:  Revenues and Market Share of Major Medical Device Recall Management Service Providers

  • Collection of medical-device-recall-management-specific revenues from annual reports, SEC filings, investor presentations, earnings transcripts, company websites, press releases, service portfolios, and regulatory disclosures.
  • Analysis of leading in-scope service providers such as Sedgwick, IQVIA Inc., Inmar Intelligence, Wipro Limited, RQM+, Quest International, DHL Supply Chain, UPS Healthcare, Freyr Solutions, UL Solutions/Emergo by UL, CEVA Logistics, GXO Logistics, Recall InfoLink, Ameridial, and EnPak LLC.
  • Assessment of revenues attributable specifically to recall strategy and compliance, stakeholder notification, recall execution and case management, product retrieval and reverse logistics, field correction, reconciliation, and recall closure.
  • Estimation of recall-management revenues based on medical-device client penetration, number of recall engagements, geographic reach, service breadth, field-service capacity, contact-center infrastructure, and reverse-logistics capabilities.
  • Allocation of only medical-device-recall-related revenues for diversified companies such as DHL, UPS, Wipro, CEVA Logistics, GXO, and UL Solutions, excluding unrelated logistics, IT, consulting, certification, and other corporate revenues.
  • Adjustment for overlapping regulatory, logistics, field-service, subcontracting, and technology-provider revenues to prevent double counting across participants involved in the same recall program.
  • Triangulation of provider-level revenues with recall-event volumes, affected-device populations, outsourcing penetration, and country-level recall activity to derive the global market estimate.

Approach 2: Recall Event, Service Intensity and Contract Value Analysis

  • Identification of medical device recalls, corrections, removals, Field Safety Corrective Actions, safety notices, and other qualifying recall-related events across major countries and regions.
  • Classification of recall events into product removal & return, on-site correction, repair & modification, software/firmware correction, relabeling & replacement, and other qualifying corrective actions.
  • Assessment of recall severity, affected device units, number of consignees, healthcare facilities involved, patient-level outreach requirements, geographic coverage, and duration of each recall program.
  • Mapping of service requirements across recall strategy and regulatory support, notification and communication, case management, product retrieval, reverse logistics, field correction, effectiveness checks, reconciliation, and regulatory closure.
  • Estimation of average service contract value per recall based on recall complexity, affected-unit volume, number of countries involved, service intensity, regulatory requirements, logistical complexity, and field-service requirements.
  • Application of an outsourced recall-management penetration rate to separate third-party service revenues from recall activities managed internally by medical-device manufacturers.
  • Calculation of market size using annual qualifying recall events × outsourced service penetration × average recall-management service value per event.
  • Aggregation of country- and region-level recall-event estimates to derive regional and global market values and cross-validation with service-provider revenue estimates.

Approach 3:  Country-Level Recall Activity, Medical Device Exposure and Spending Model

  • Assessment of annual medical device recall, correction, removal, Field Safety Corrective Action, and safety-notification activity across the U.S., Canada, Europe, Japan, China, India, Australia, Southeast Asia, Latin America, and the Middle East & Africa.
  • Evaluation of each country's medical-device installed base, domestic manufacturing activity, import dependence, healthcare infrastructure, device utilization, connected-device penetration, and number of active medical-device manufacturers and distributors.
  • Analysis of regulatory enforcement intensity, post-market surveillance frameworks, adverse-event reporting requirements, traceability requirements, recall classification systems, and recall-compliance obligations.
  • Estimation of country-level outsourcing penetration for regulatory recall support, stakeholder communication, field actions, reverse logistics, software correction, reconciliation, and closure.
  • Assessment of average recall-management expenditure per event, adjusted for labor costs, logistics costs, geographic size, affected-unit volume, regulatory complexity, and local service-provider availability.
  • Comparison of mature markets such as the U.S., Western Europe, Japan, and Australia with emerging markets based on regulatory maturity, device penetration, recall frequency, outsourcing adoption, and service pricing.
  • Estimation of country-level recall management services spending followed by aggregation into North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the global market.
  • Triangulation of country-level estimates with company revenues, regulatory recall databases, affected-device volumes, and observed provider activity.

2. Top Down Approaches

Approach 1: Analysis of the Parent Medical Device Market and Recall-Service Addressable Pool

  • Analysis of the global medical-device industry as the broader parent market supporting the installed base and commercial activity from which medical-device recalls originate.
  • Estimation of medical-device exposure across implantable devices, capital & durable equipment, disposable devices, IVD devices, connected & software-enabled devices, and other qualifying medical-device categories.
  • Assessment of the proportion of commercially distributed medical devices exposed annually to recalls, corrections, removals, safety actions, software updates, or other qualifying field corrective actions.
  • Application of country- and device-specific recall frequency, affected-unit intensity, regulatory enforcement, and post-market surveillance factors to estimate the total addressable recall-management activity.
  • Estimation of the share of total recall-management activity outsourced to specialist recall providers, regulatory consultants, field-service companies, logistics providers, and technology-enabled recall-management companies.
  • Application of average recall-management service expenditure as a percentage of the addressable recall activity, excluding the value of recalled devices, replacement products, litigation, insurance claims, and manufacturers' internal recall expenses.
  • Comparison of the top-down estimate with company-revenue, recall-event, contract-value, and country-level spending models to finalize the global market size.

Approach 2: Regulatory Recall Incidence and Medical Device Installed-Base Analysis

  • Collection of medical-device recall, correction, removal, safety-notice, and field-action data from major regulators including the U.S. FDA, European regulatory authorities, MHRA, PMDA/MHLW, NMPA, CDSCO, and TGA.
  • Estimation of recall-event intensity relative to the medical-device installed base, number of registered devices, device manufacturers, and healthcare facilities across major countries.
  • Analysis of changes in recall frequency and complexity arising from connected devices, software-enabled devices, cybersecurity vulnerabilities, remote software updates, and increasingly complex global supply chains.
  • Application of regional differences in regulatory scrutiny, recall depth, notification requirements, effectiveness checks, traceability, and field-action requirements.
  • Adjustment for the proportion of recalls requiring external regulatory support, contact-center services, field technicians, reverse logistics, device tracking, and reconciliation.
  • Conversion of the estimated outsourced workload into market value using region-specific service pricing and average contract-value assumptions.
  • Validation of the resulting top-down estimate against bottom-up service-provider revenues and country-level recall-management expenditure.

3. List of Key Sources

  • Annual reports, SEC filings, investor presentations, earnings transcripts, financial disclosures, and service-specific revenue disclosures of recall-management service providers
  • Company websites, medical-device recall service portfolios, case studies, press releases, acquisitions, partnerships, geographic expansion announcements, and technology investments
  • S. Food and Drug Administration (FDA) medical device recalls, corrections and removals databases, enforcement reports, recall classifications, Medical Device Reporting data, UDI information, and Quality Management System requirements
  • European Commission, EU Medical Device Regulation, EUDAMED-related information, Field Safety Corrective Actions, Field Safety Notices, vigilance requirements, and national competent authorities
  • K. Medicines and Healthcare products Regulatory Agency (MHRA) safety alerts and medical-device corrective actions
  • PMDA and Ministry of Health, Labour and Welfare (MHLW), Japan
  • National Medical Products Administration (NMPA), China
  • Central Drugs Standard Control Organisation (CDSCO), India
  • Therapeutic Goods Administration (TGA), Australia
  • Medical Device Manufacturers Association (MDMA), AdvaMed, MedTech Europe, CAMDI, Medical Technology Association of Australia, and other national medical-technology associations
  • WHO, OECD, World Bank, Eurostat, and national healthcare and regulatory statistical agencies
  • National medical-device registration, adverse-event, recall, vigilance, and safety-notification databases
  • Medical-device Field Safety Notices, Field Safety Corrective Actions, warning letters, enforcement actions, safety communications, and regulatory inspection findings
  • Medical-device manufacturer recall announcements, customer notifications, Dear Healthcare Professional letters, device correction notices, and software/firmware remediation notices
  • UDI, serialization, barcode, RFID, device traceability, and supply-chain data where available
  • Healthcare facility, hospital, distributor, and supply-chain data used to estimate recall depth and affected-customer populations
  • Recall-related reverse-logistics, product retrieval, field-service, call-center, destruction, remediation, and reconciliation activity
  • M&A transactions, partnerships, acquisitions, technology deployments, service-capacity expansions, and geographic expansions involving recall-management providers
  • Peer-reviewed publications, regulatory guidance documents, post-market surveillance studies, medical-device safety literature, and healthcare supply-chain research
  • Third-party market-research publishers are excluded as primary evidence sources.
  • Peer-reviewed epidemiological studies, clinical guidelines, stoma-care publications, and patient-utilization studies
  • Product launches, regulatory approvals, distribution agreements, acquisitions, partnerships, geographic expansions, and reimbursement developments

5. Primary Interviews

Supply Side Interviews: 60%

  • Key Respondents:
    • Medical device recall management service providers
    • Product recall and crisis-management specialists
    • Regulatory affairs and medical-device compliance consultants
    • Recall program directors and field-action managers
    • Medical-device quality assurance and post-market surveillance executives
    • Medical-device manufacturer recall coordinators
    • Regulatory affairs, quality, vigilance, and CAPA professionals
    • Reverse-logistics and product-retrieval service providers
    • Healthcare logistics and supply-chain executives
    • Field-service, device-repair, and remediation providers
    • Contact-center and stakeholder-notification service providers
    • Recall-management software and technology-platform providers
    • UDI, serialization, traceability, RFID, and device-tracking solution providers
    • Commercial, business-development, sales, and account-management executives
    • Importers, distributors, authorized representatives, and OEM/contract manufacturing organizations
  • Key Discussion Areas:
    • Number and complexity of medical-device recall engagements
    • Average recall-management contract values
    • Service mix and revenue distribution
    • Outsourcing penetration
    • Customer and device-category mix
    • Geographic coverage
    • Pricing and contract structure
    • Field-service and reverse-logistics requirements
    • Software/firmware recall activity
    • Recall technology adoption
    • Competitive positioning
    • Growth expectations and market outlook

Demand Side Interviews: 40%

  • Key Respondents:
    • Medical device manufacturers
    • Contract manufacturers and OEMs
    • Medical-device importers and distributors
    • Hospital and health-system procurement executives
    • Hospital supply-chain and inventory-management professionals
    • Hospital quality and patient-safety teams
    • Biomedical and clinical engineering departments
    • Regulatory affairs and post-market surveillance professionals
    • Healthcare risk-management executives
    • Medical-device safety officers
    • Group purchasing organizations and healthcare procurement networks
    • Regulatory and compliance experts
    • Healthcare-system logistics and product-return coordinators
  • Key Discussion Areas:
    • Frequency and type of medical-device recalls managed annually
    • Extent of recall-management outsourcing
    • Selection criteria for third-party recall service providers
    • Spending on regulatory, communication, field-action, logistics, and closure services
    • Recall response time and effectiveness requirements
    • Device identification and traceability capabilities
    • Patient and healthcare-provider notification requirements
    • Challenges associated with multi-country and large-scale recalls
    • Adoption of digital recall-management and tracking platforms
    • Software/firmware and connected-device corrective-action requirements
    • Expected changes in recall-management budgets and outsourcing over the forecast period
    • Regulatory, operational, and technology factors influencing future service demand


Frequently Asked Questions

Fortune Business Insights says that the global market value stood at USD 1.68 billion in 2025 and is projected to reach USD 3.30 billion by 2034.

In 2025, the market value in North America stood at USD 0.78 billion.

The market is expected to exhibit a CAGR of 7.8% during the forecast period.

By service type, the retrieval & reverse logistics segment led the market.

The key factors driving the market is the rising medical-device recalls and regulatory scrutiny.

IQVIA Inc., Sedgwick, Inmar Inc., and Wipro Limited are among the top players in the market.

North America dominated the market in 2025.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 250
Download Free Sample

    man icon
    Mail icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann